Capital Research Global Investors Boston Scientific Corp Call Options Transaction History
Capital Research Global Investors
- $463 Billion
- Q3 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding BSX
# of Institutions
1,611Shares Held
1.19BCall Options Held
6.83MPut Options Held
10.1M-
Vanguard Group Inc Valley Forge, PA133MShares$14.1 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$13.4 Billion0.22% of portfolio
-
State Street Corp Boston, MA62.8MShares$6.66 Billion0.22% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.91 Billion2.61% of portfolio
-
Wellington Management Group LLP Boston, MA36.2MShares$3.83 Billion0.61% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $152B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...